BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 23103103)

  • 1. [Clinical factors associated with invasive pulmonary aspergillosis in patients with chronic pneumopathies and respiratory isolation of Aspergillus spp].
    Castón JJ; Linares MJ; Rivero A; Casal M; Torre-Cisneros J
    Med Clin (Barc); 2012 Dec; 139(15):668-71. PubMed ID: 23103103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of Aspergillus spp. isolation from lower respiratory tract samples for the diagnosis and prognosis of invasive pulmonary aspergillosis in chronic obstructive pulmonary disease.
    He HY; Chang S; Ding L; Sun B; Li F; Zhan QY
    Chin Med J (Engl); 2012 Sep; 125(17):2973-8. PubMed ID: 22932166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features and prognostic analysis of patients with Aspergillus isolation during acute exacerbation of chronic obstructive pulmonary disease.
    Gu Y; Ye X; Wang Y; Shen K; Zhong J; Chen B; Su X
    BMC Pulm Med; 2021 Feb; 21(1):69. PubMed ID: 33637057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome.
    Guinea J; Torres-Narbona M; Gijón P; Muñoz P; Pozo F; Peláez T; de Miguel J; Bouza E
    Clin Microbiol Infect; 2010 Jul; 16(7):870-7. PubMed ID: 19906275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: a case control study from China.
    Xu H; Li L; Huang WJ; Wang LX; Li WF; Yuan WF
    Clin Microbiol Infect; 2012 Apr; 18(4):403-8. PubMed ID: 22023558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Aspergillus-related respiratory conditions and COPD: Diagnostic challenges].
    Ehret N; Carlier N; Marey J; Rabbat A; Burgel PR; Roche N
    Rev Mal Respir; 2020 Apr; 37(4):308-319. PubMed ID: 32284206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasive pulmonary aspergillosis in patients with solid tumours: risk factors and predictors of clinical outcomes.
    Dandachi D; Wilson Dib R; Fernández-Cruz A; Jiang Y; Chaftari AM; Hachem R; Raad I
    Ann Med; 2018 Dec; 50(8):713-720. PubMed ID: 30230385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics, radiologic findings, risk factors and outcomes of serum galactomannan-negative invasive pulmonary aspergillosis.
    Jung J; Kim MY; Chong YP; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH
    J Microbiol Immunol Infect; 2018 Dec; 51(6):802-809. PubMed ID: 28712819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invasive pulmonary aspergillosis in non-neutropenic patients: analysis of a 14-month prospective clinical experience.
    Russo A; Falcone M; Vena A; Venditti C; Mancini C; Morelli A; Venditti M
    J Chemother; 2011 Oct; 23(5):290-4. PubMed ID: 22005062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of invasive aspergillosis in patients with COPD: rational use of voriconazole.
    Ader F; Bienvenu AL; Rammaert B; Nseir S
    Int J Chron Obstruct Pulmon Dis; 2009; 4():279-87. PubMed ID: 19684861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic significance of Aspergillus species isolated from respiratory samples in an adult pneumology ward.
    Tashiro T; Izumikawa K; Tashiro M; Takazono T; Morinaga Y; Yamamoto K; Imamura Y; Miyazaki T; Seki M; Kakeya H; Yamamoto Y; Yanagihara K; Yasuoka A; Kohno S
    Med Mycol; 2011 Aug; 49(6):581-7. PubMed ID: 21208028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effectiveness of Culture-Directed Preemptive Anti-Aspergillus Treatment in Lung Transplant Recipients at One Year After Transplant.
    Hosseini-Moghaddam SM; Chaparro C; Luong ML; Azad S; Singer LG; Mazzulli T; Rotstein C; Keshavjee S; Husain S
    Transplantation; 2015 Nov; 99(11):2387-93. PubMed ID: 25961491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 associated with pulmonary aspergillosis: A literature review.
    Lai CC; Yu WL
    J Microbiol Immunol Infect; 2021 Feb; 54(1):46-53. PubMed ID: 33012653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasive pulmonary aspergillosis is associated with adverse clinical outcomes in critically ill patients receiving veno-venous extracorporeal membrane oxygenation.
    Rodriguez-Goncer I; Thomas S; Foden P; Richardson MD; Ashworth A; Barker J; Geraghty CG; Muldoon EG; Felton TW
    Eur J Clin Microbiol Infect Dis; 2018 Jul; 37(7):1251-1257. PubMed ID: 29623451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19-associated pulmonary aspergillosis (CAPA): identification of Aspergillus species and determination of antifungal susceptibility profiles.
    Ozturk A; Bozok T; Erdogan M; Ibrahim BM; Bozok TS
    Folia Microbiol (Praha); 2023 Dec; 68(6):951-959. PubMed ID: 37294497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drivers and impact of antifungal therapy in critically ill patients with Aspergillus-positive respiratory tract cultures.
    Paiva JA; Mergulhão P; Gomes A; Taccone FS; Van den Abeele AM; Bulpa P; Misset B; Meersseman W; Dimopoulos G; Rello J; Vogelaers D; Blot S
    Int J Antimicrob Agents; 2017 Oct; 50(4):529-535. PubMed ID: 28669830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is Bulpa criteria suitable for the diagnosis of probable invasive pulmonary Aspergillosis in critically ill patients with chronic obstructive pulmonary disease? A comparative study with EORTC/ MSG and ICU criteria.
    Huang L; He H; Jin J; Zhan Q
    BMC Infect Dis; 2017 Mar; 17(1):209. PubMed ID: 28292284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of Aspergillosis in a cohort of non-neutropenic, non-transplant patients colonised by Aspergillus spp.
    Barberán J; García-Pérez FJ; Villena V; Fernández-Villar A; Malmierca E; Salas C; Giménez MJ; Granizo JJ; Aguilar L;
    BMC Infect Dis; 2017 Jan; 17(1):34. PubMed ID: 28056830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Report of 38 cases of tracheobronchitis in non-immunocompromised patients with dual isolation of Aspergillus in lower respiratory tract samples.
    Barberán J; Sánchez-Haya E; del Castillo D; Sanz F; Alcázar B; Malmierca E;
    Rev Esp Quimioter; 2014 Jun; 27(2):110-4. PubMed ID: 24940892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular typing and antifungal susceptibility study of Aspergillus spp. in intensive care unit (ICU) patients in Indonesia.
    Rozaliyani A; Sedono R; Sjam R; Tugiran M; Adawiyah R; Setianingrum F; Jusuf A; Sungkar S; Hagen F; Meis JF; Wahyuningsih R
    J Infect Dev Ctries; 2021 Jul; 15(7):1014-1020. PubMed ID: 34343127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.